INDUSTRY INSIGHT
EYE HEALTH
SPONSORED CONTENT
AIO TREATS
MACULAR
DEGENERATION
WITH EVERYTHING
THEY GOT
Macular Degeneration is the #1 cause of blindness in people over 50 years of
age. It is caused by the breakdown of the central portion of the retina called
the macula, the nerve layer part of the eye that works like the film in a camera
to create a picture. The macula is responsible for the fine central vision in the
eye that is needed for driving a car, reading, and recognizing faces.
The doctors of AIO’s retinal service are board-certified
ophthalmologists and fellowship trained offering you a full complement
of advanced vision treatments with state-of-the-art technology in
combatting vision problems. At AIO (Associates in Ophthalmology) we
offer the latest medications, non-invasive techniques, corrective surgery,
advanced laser procedures and leading-edge therapies developed by the
AIO clinical research team, you can expect true visionary eye care.
Painless Treatment Options: Our experienced retina surgeons are
skilled in a variety of painless, non-invasive and minimally-invasive
procedures.
Medical Treatments: Our doctors select from the most effective drugs
on the market to treat AMD, such as inhibitor injections that treat and
prevent the unwanted growth of tiny vessels responsible for vision
loss in macular degeneration. They also stay up-to-date on the newest
medical treatments and incorporate them into each patient’s customized
treatment plan.
Micro-Incision Vitrectomy Surgery (MIVS): Our surgeons are
experienced and skilled in advanced micro-incision surgery. The small
incision no-stitch surgery is gentle on the eye, increases postoperative
comfort and promotes a faster visual recovery. Our new revolutionary
NGENUITY® 3D System provides our operating team and surgeons the
most advanced and precise visualization equipment available.
Nutritional Supplements: The right daily levels of the clinically proven
AREDS 2 formulation eye vitamins are a simple, yet
effective means to slow the progress of macular
degeneration. In fact, AIO has developed its own
customized formula of nutritional supplements
which are available for purchase at your
convenience.
Photodynamic Laser Therapy: PTD is a painless,
effective treatment for wet macular degeneration,
which can be performed right in the office. It is often combined with a
simple injection of medication, and the laser therapy can successfully
slow the progression of wet macular degeneration.
Clinical Research Trials: Our surgeons participate in and monitor
the latest developments in vision care, allowing them to access the
most advanced treatments available. We have new and exciting
opportunities in the latest clinical trials so that our patients can
participate and benefit from
the latest advances.
The Latest Dry AMD
Research:
AIO has been selected as a
site for the Ophthotech OPH2003 clinical trial, which is investigating
a new medication called ZIMURA for the treatment of dry age-
related macular degeneration. It is believed that ZIMURA interrupts
the degenerative disease process that causes central vision loss in
DARMD (Dry Age-Related Macular Degeneration). ZIMURA is given as
an injection into the eye. Patients selected for the clinical trial will be
examined monthly for 18 months.
The objectives of this study are to evaluate the safety and effectiveness
of ZIMURA when administered in research participants with DARMD.
The study will involve approximately 200 men and women over the age
of 50 years worldwide. For more information on this trial, please contact
the Research Department directly at 412.653.3080
x1041.
Is it time to take advantage of these advanced
treatment options for keeping your vision the best
it can be? For more information, visit AIOvision.com
or call 412.653.3080 to schedule your appointment
with one of our experienced retinal specialists.
2790 Mosside Blvd, Suite 200 Monroeville, PA 15146
AIOvision.com
1.800.246.1000
C ATA R AC T S | C O R N E A | G L AU C OM A | L A SI K | R E T I NA | L I F E ST Y L E L E N SE S
WOODLAND HILLS ❘
SPRING 2018
7